Y-mAbs Therapeutics, Inc.
YMAB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$29,666 | -$21,427 | -$95,568 | -$55,275 |
| Dep. & Amort. | $535 | $735 | $839 | $782 |
| Deferred Tax | $0 | $0 | $0 | $1,897 |
| Stock-Based Comp. | $14,559 | $14,453 | $25,603 | $19,334 |
| Change in WC | -$3,649 | -$19,734 | -$10,371 | -$7,284 |
| Other Non-Cash | $2,507 | -$1,259 | $3,576 | -$62,010 |
| Operating Cash Flow | -$15,714 | -$27,232 | -$75,921 | -$102,556 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$967 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $62,010 |
| Investing Cash Flow | $0 | $0 | $0 | $61,043 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $4,311 | $100 | $84 | $107,725 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $589 |
| Financing Cash Flow | $4,311 | $100 | $84 | $108,314 |
| Forex Effect | $0 | $7 | $35 | $129 |
| Net Chg. in Cash | -$11,403 | -$27,125 | -$75,802 | $66,930 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $78,637 | $105,762 | $181,564 | $114,634 |
| End Cash | $67,234 | $78,637 | $105,762 | $181,564 |
| Free Cash Flow | -$15,714 | -$27,232 | -$75,921 | -$103,523 |